Overview

Antibiotic Prophylaxis in High-Risk Arthroplasty Patients

Status:
Recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
To determine the effectiveness of a 7-day course of an oral, prophylactic antibiotic on the incidence of periprosthetic joint infection and wound complications following primary total hip and knee arthroplasty in a high-risk patient population.
Phase:
Phase 4
Details
Lead Sponsor:
University of Iowa
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Cefadroxil
Cephalexin
Clindamycin
Doxycycline
Sulfamethoxazole
Trimethoprim
Trimethoprim, Sulfamethoxazole Drug Combination